Research Partnership welcomes Jeanne Penn
We are delighted to announce that Jeanne Penn has joined the Singapore office as a Senior Research Executive.
Jeanne previously worked at Cello Health Insight in New York City on the qualitative team, where she was involved in all parts of the research process, from writing proposals to delivering reports. She’s worked in various therapy areas, and has a particular interest in rare diseases and mental health. In a prior role, she co-led the first Diversity & Inclusion initiative and was awarded the Young Professionals Grant to attend the Qualitative Research Consultants Association (QRCA) conference. Jeanne graduated from Hamilton College, and interned at Hall & Partners where she was first introduced to healthcare market research.
Therapy Watch appoints new Associate Director
Research Partnership is delighted to welcome Mark Hollis who has joined the Therapy Watch team in London.
Mark has 8 years’ experience in syndicated healthcare, and previously worked in the Market Prognosis team at IQVIA (IMS Health), where he led field work, analytics, forecasting and report writing for the Middle East and North Africa region.
Sabera Hyderally appointed Head of MedTech North America
Research Partnership is delighted to welcome Sabera Hyderally who has joined the company’s US headquarters in Philadelphia.
Sabera has over 20 years’ experience in market research, specifically on the agency side. Most recently she was at Lieberman where for the last 7 years she held the position of Executive Vice President of Health.
Dan Coffin joins London Headquarters as Director
Research Partnership is delighted to welcome Dan Coffin who has joined the company’s global head office in London
Dan Coffin joins Research Partnership as Director for the EU region. Dan has over 18 years’ experience in the pharmaceutical sector, with particular interest in digital therapy and the growing health-tech arena. Dan brings experience from the agency side, strengthened by client-side roles at Roche and Johnson & Johnson. Most recently, Dan was employed at Illuminas where he established and ran their healthcare market research arm. He is an active industry contributor and has been a BHBIA Board director since 2013.